Yan Moore - 28 Feb 2023 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGAQ)

Role
Chief Medical Officer
Signature
/s/ Barbara Chan as Attorney-in-Fact for Yan Moore
Issuer symbol
OMGAQ
Transactions as of
28 Feb 2023
Net transactions value
$0
Form type
4
Filing time
02 Mar 2023, 15:05:46 UTC
Previous filing
28 Oct 2022
Next filing
09 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMGA Option (Right to Buy) Award $0 +55,000 $0.000000 55,000 28 Feb 2023 Common Stock 55,000 $6.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable with respect to 25% of the underlying shares on February 28, 2024 and in equal quarterly installments thereafter such that the option will become fully vested and exercisable on February 28, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date.